hFCRN/hALB(SD)

Nomenclature

SD-Fcgrtem1(hFCGRT)Albem3(hALB)Smoc

Cat. NO.

NR-HU-233317

Strain State

Repository Live

Export PDF

Gene Summary

Model Description

The hALB(SD)(NR-HU-200001) was crossed with hFCRN(SD)(NR-HU-200002) to generate hFCRN(SD)/hALB(SD) mice.

Validation Data

image.png

Fig.1 Detection of ALB expression in serum by blood biochemical analysis (n=4). 

Abbr. HO, homozygous; WT, wild type.


image.png

Fig.2 Detection of hALB (A) and rALB (B) expression in serum by ELISA (n=3). 

Abbr. HO, homozygous; WT, wild type.

image.png

Fig.3 Expression characterization of hFCRN in hALB/hFCRN dKI rat by Western blot. (Arrow indicates expected molecular weight and asterisk indicates a nonspecific band)   


image.png

Fig.4  Blood concentration curve of test articles in hFcRn/hALB dKI rats. 

In hFcRn/hALB dKI rats, the half-life time: TA-N434A > TA-YTE > TA. (In cooperation with the third party) 


image.png

Fig.5 PK study of Keytruda in  hALB/hFCRN dKl rat. (n=3/time point/group)  


image.png

Fig.6 PK study of Cyramza in hALB/hFCRN dKI rat. (n=3/time point/group)  

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop：Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more